Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer's Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study

Benzer Materyaller

• Placebo treatment in mild to moderate depression
  Yazar:: Pittrof, Rudiger
  Baskı/Yayın Bilgisi: (2011)
• ABT-126 monotherapy in mild-to-moderate Alzheimer’s dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension
  Yazar:: Gault, Laura M., ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Two randomized controlled trials of SB742457 in mild-to-moderate Alzheimer's disease
  Yazar:: Maher-Edwards, Gareth, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial
  Yazar:: Dubée, Vincent, ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• Olsalazine versus placebo in the treatment of mild to moderate ulcerative colitis: a randomised double blind trial.
  Yazar:: Feurle, G E, ve diğerleri
  Baskı/Yayın Bilgisi: (1989)